Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for MACUGEN
- Plasma Levels of Vascular Endothelial Growth Factor Before and After Intravitreal Injection of Aflibercept
- Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival
- A Study of the Safety, Tolerability, and Efficacy of IVT Pre-op 0.3mg Pegaptanib Sodium Versus Sham, for Management of Tractional Retinal Detachment and Vitreous Hemorrhage With Proliferative Diabetic Retinopathy
- Extension Study to Gather Data on Effect of Macugen on the Corneal Endothelium
- Intraoperative Dexamethasone Implant Improves Outcome of Cataract Surgery With Diabetic Macular Edema
- A Single-Center Trial of Intravitreous Injections of Macugen (Pegaptanib Sodium) Given at Least 7 Days Before Vitrectomy Secondary To Tractional Retinal Detachment in Proliferative Diabetic Retinopathy
- Macugen for Proliferative Diabetic Retinopathy Study With Extended Dosing (M-PDRS ED)
- Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study
- Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the Treatment With High Risk PDR.
- Observational Study Of The Long-Term Effect Of Macugen In Patients With Wet Age-Related Macular Degeneration
- Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP)
- Intravitreal Pegaptanib in Treatment of Choroidal Neovascularisation Secondary to Pathologic Myopia
- Intravitreal Macugen for Ischaemic Diabetic Macular Oedema
- Use of Pan-Vascular Endothelial Growth Factor Receptor (Pan-VEGF) Blockade for the Treatment of Retinopathy of Prematurity (ROP) (Compassionate Use BLOCK-ROP)
- Efficacy And Safety Of Macugen In Patients With Neovascular AMD In Routine Clinical Practice.
- Long-Term Use Of Pegaptanib In Patients For Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration
- Lucentis to Treat Pigment Epithelial Detachment
- Efficacy, Safety, Tolerability of Pegaptanib Sodium (Macugen) in Filipino Patients With Neovascular Age Related Macular Degeneration.
- Investigates Improvement in Vision Following Switching From Avastin and Macugen Over to Lucentis
- Pegaptanib Therapy in Non-Infectious Uveitic Cystoid Macular Edema
- Subretinal Macugen® for Neovascular Age-Related Macular Degeneration
- The Effect of a Single Intravitreal Anti-VEGF Therapy on Optic Nerve Head Perfusion
- Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity
- Intraocular Anti-VEGF Compared With Intraocular Triamcinolone in Patients With Diabetic Macular Edema
- A Multi-Center Trial To Evaluate The Safety And Efficacy Of Pegaptanib Sodium(Macugen) Injected Into The Eye Every 6 Weeks For Up To 2 Years For Macular Swelling Associated With Diabetes, With An Open-Label Macugen Year Extension.
- A Study On The Efficacy Of Macugen Injections In Patients With Neovascular Age-Related Macular Degeneration In Real Life.
- Bevacizumab Versus Ranibizumab for Diabetic Retinopathy
- MAAM Study: Avastin and Macugen Versus Avastin Versus Macugen
- Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration
- Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema)
- Evaluation of Macugen Treatment of Macular Edema Due to Branch Retinal Vein Occlusion
- Intravitreal Bevacizumab for Retinal Disorders
- The Effect of Macugen in Patients With Chronic, Post-Operative Cystoid Macular Edema
- A Clinical Trial to Explore the Safety and Efficacy of Injections of Macugen When Given Every 6 Weeks in Subjects With AMD
- Macugen to Prevent Worsening of Macular Edema Following Cataract Surgery in Diabetics
- An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD
- Evaluation Of Safety And Efficacy Of 0.3 Mg/Eye Macugen In Patients With Small Age-Related Macular Degeneration Lesions
- Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD
- Macugen for Histoplasmosis
- A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib
- Macugen (Pegaptanib Sodium) Alone, Versus Macugen in Combination With PDT (Photodynamic Therapy) With Visudyne (Verteporfin) in Patients With Age-Related Macular Degeneration (AMD)
- Pegaptanib Sodium Compared to Sham Injection in Patients With Recent Vision Loss Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO)
- Pegaptanib Sodium on Foveal Thickening in Patients With Exudative Subfoveal Age-Related Macular Degeneration (AMD)
- Pegaptanib Sodium Compared to Sham Injection in Patients With DME Involving the Center of the Macula
Clinical trials list
click for details